Macular and Retinal Nerve Fibre Layer Thickness in Pregnant Women with Gestational Diabetes Mellitus.
gestational diabetes mellitus
healthy women
macular thickness
pregnant women
retinal nerve fibre layer thickness
Journal
Clinical ophthalmology (Auckland, N.Z.)
ISSN: 1177-5467
Titre abrégé: Clin Ophthalmol
Pays: New Zealand
ID NLM: 101321512
Informations de publication
Date de publication:
2020
2020
Historique:
received:
21
01
2020
accepted:
02
04
2020
entrez:
23
5
2020
pubmed:
23
5
2020
medline:
23
5
2020
Statut:
epublish
Résumé
The information about macular and retinal nerve fibre layer (RNFL) thickness in women with gestational diabetes mellitus (GDM) is scarce. GDM is a risk factor for development of type 2 diabetes mellitus. The purpose of this study was to evaluate mean macular and RNFL thickness in pregnant women with GDM in a teaching institution in Malaysia. We also analyzed the association of age, HbA1c level, duration of GDM, type of treatment, family history, previous history of GDM and spherical equivalent with the macular and RNFL thickness. This was a prospective and cross-sectional study involving 78 pregnant women with GDM, 72 healthy pregnant and 70 healthy non-pregnant women. The study was conducted in Hospital Universiti Sains Malaysia from 2016 to 2018. Macular and RNFL thickness were measured during the third trimester using spectral-domain optical coherence tomography. Age, HbA1c level, duration of GDM, type of treatment, family history, previous history of GDM and spherical equivalent were analysed. The mean macular thickness was 236.08 (16.44) µm, 237.26 (22.42) µm and 240.66 (20.95) µm for GDM, healthy pregnant, and healthy non-pregnant women. The mean RNFL thickness was 97.27 (9.14) µm, 99.83 (12.44) µm and 97.97 (10.07) µm for GDM, healthy pregnant, and healthy non-pregnant women. There was no significant difference in the mean macular and RNFL thickness in pregnant women with GDM when compared to the control groups (p>0.05). Age, HbA1c, duration of diabetes, treatment received, history of GDM and spherical equivalent did not show significant association with mean macular and retinal thickness (p>0.05). Pregnant women with GDM have similar thickness of the macular and RNFL with the healthy pregnant and healthy non-pregnant women. Age, HbA1c, duration of diabetes, treatment received, history of GDM and spherical equivalent showed no significant association with mean macular and retinal thickness in pregnant women with GDM.
Sections du résumé
BACKGROUND
BACKGROUND
The information about macular and retinal nerve fibre layer (RNFL) thickness in women with gestational diabetes mellitus (GDM) is scarce. GDM is a risk factor for development of type 2 diabetes mellitus.
PURPOSE
OBJECTIVE
The purpose of this study was to evaluate mean macular and RNFL thickness in pregnant women with GDM in a teaching institution in Malaysia. We also analyzed the association of age, HbA1c level, duration of GDM, type of treatment, family history, previous history of GDM and spherical equivalent with the macular and RNFL thickness.
PATIENTS AND METHODS
METHODS
This was a prospective and cross-sectional study involving 78 pregnant women with GDM, 72 healthy pregnant and 70 healthy non-pregnant women. The study was conducted in Hospital Universiti Sains Malaysia from 2016 to 2018. Macular and RNFL thickness were measured during the third trimester using spectral-domain optical coherence tomography. Age, HbA1c level, duration of GDM, type of treatment, family history, previous history of GDM and spherical equivalent were analysed.
RESULTS
RESULTS
The mean macular thickness was 236.08 (16.44) µm, 237.26 (22.42) µm and 240.66 (20.95) µm for GDM, healthy pregnant, and healthy non-pregnant women. The mean RNFL thickness was 97.27 (9.14) µm, 99.83 (12.44) µm and 97.97 (10.07) µm for GDM, healthy pregnant, and healthy non-pregnant women. There was no significant difference in the mean macular and RNFL thickness in pregnant women with GDM when compared to the control groups (p>0.05). Age, HbA1c, duration of diabetes, treatment received, history of GDM and spherical equivalent did not show significant association with mean macular and retinal thickness (p>0.05).
CONCLUSION
CONCLUSIONS
Pregnant women with GDM have similar thickness of the macular and RNFL with the healthy pregnant and healthy non-pregnant women. Age, HbA1c, duration of diabetes, treatment received, history of GDM and spherical equivalent showed no significant association with mean macular and retinal thickness in pregnant women with GDM.
Identifiants
pubmed: 32440087
doi: 10.2147/OPTH.S245054
pii: 245054
pmc: PMC7211316
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1215-1221Informations de copyright
© 2020 Tengku-Fatishah et al.
Déclaration de conflit d'intérêts
The authors report no conflict of interest in this work.
Références
Curr Pharm Des. 2009;15(9):1027-33
pubmed: 19275665
BMC Ophthalmol. 2017 Jan 18;17(1):4
pubmed: 28100181
Acta Ophthalmol Scand. 2007 Feb;85(1):46-9
pubmed: 17244209
BMC Pregnancy Childbirth. 2019 Nov 27;19(1):448
pubmed: 31775681
Int Ophthalmol. 2018 Oct;38(5):2069-2076
pubmed: 28879527
Invest Ophthalmol Vis Sci. 2011 Feb 28;52(2):1156-63
pubmed: 21357409
Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2715-9
pubmed: 22427582
Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1289-93
pubmed: 17226022
Gynecol Obstet Invest. 2014;77(3):145-9
pubmed: 24401480
Acta Ophthalmol. 2018 Mar;96(2):174-182
pubmed: 29090852
Graefes Arch Clin Exp Ophthalmol. 2015 Nov;253(11):1915-21
pubmed: 26067394
Med Sci Monit. 2015 Jun 18;21:1759-64
pubmed: 26084958
Clin Ophthalmol. 2018 Jul 17;12:1259-1265
pubmed: 30050277
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
pubmed: 24357215
J Diabetes Res. 2018 Feb 25;2018:3082893
pubmed: 29682578
Surv Ophthalmol. 2013 Mar-Apr;58(2):127-42
pubmed: 23410822
Curr Diab Rep. 2016 Jan;16(1):7
pubmed: 26742932
J Diabetes Res. 2018 Feb 20;2018:6536974
pubmed: 29675432
J Endocrinol Invest. 2017 Sep;40(9):899-909
pubmed: 28283913